
About Recuro Pharma Private Limited
Data last updated:
Recuro Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2011PTC076482. Its GSTIN is 36AAKCA1858P1Z2 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹26 Lakh and a paid-up capital of ₹26 Lakh. It was formerly known as Abhay Sai Pharma Labs Private Limited. It is led by directors Mrutyumjaya Penumanchili and Saisakuntala Pandi.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Mig F 68 Block No.05 Phase V Opp. Telephone Exchange Kphb Colony, Hyderabad, Telangana, India – 500072.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website recuropharma.com.
Company details
CIN history
Recuro Pharma has one previous CIN (Corporate Identification Number): U24233AP2011PTC076482. The current CIN is U24233TG2011PTC076482, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2011PTC076482 | Current |
| U24233AP2011PTC076482 | Previous |
Contact details
Recuro Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is recuropharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressMig F 68 Block No.05 Phase V Opp. Telephone Exchange Kphb Colony, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Recuro Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Recuro Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Recuro Pharma Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Recuro Pharma Private Limited, buy the company report.
Board of directors of Recuro Pharma Private Limited
Recuro Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mrutyumjaya Penumanchili | Director | 12 Sep 2011 | 15 Years 1 Months | Current |
| Saisakuntala Pandi | Director | 12 Sep 2011 | 15 Years 1 Months | Current |
Auditor
Recuro Pharma Private Limited is audited by VAMSI SAI & SHIVA for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VAMSI SAI & SHIVA | FY 2020 | 018297S |
Shareholding
The shareholding of Recuro Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Recuro Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2015 | 10621239 | Andhra Bank | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Recuro Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Recuro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Recuro Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCA1858P1Z2 | Telangana | Active | 01 Jul 2017 |
| 37AAKCA1858P1Z0 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Recuro Pharma Private Limited, buy the company report.
Recent activity
Recuro Pharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Mrutyumjaya Penumanchili was appointed as Director on 12 Sep 2011.
Frequently asked questions
Recuro Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 September 2011 (15+ years old) and is registered under CIN U24233TG2011PTC076482.
Recuro Pharma has 2 current directors:
- Mrutyumjaya Penumanchili - Director
- Saisakuntala Pandi - Director
The latest financial statements of Recuro Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Recuro Pharma is 36AAKCA1858P1Z2, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAKCA1858P1Z0 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Recuro Pharma is U24233TG2011PTC076482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Recuro Pharma was incorporated on 12 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mrutyumjaya Penumanchili was appointed as Director on 12 Sep 2011. Saisakuntala Pandi was appointed as Director on 12 Sep 2011.
Recuro Pharma can be reached through the website recuropharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Recuro Pharma is at Mig F 68 Block No.05 Phase V Opp. Telephone Exchange Kphb Colony, Hyderabad, Telangana, India – 500072.
Recuro Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

